Wikidata

(Q64172858)

English

A Study of Baricitinib (LY3009104) in Adults With Moderate to Severe Atopic Dermatitis

clinical trial

In more languages

Statements

short name
BREEZE-AD1 (English)
0 references
title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis (English)
0 references
medical condition
dermatitis
0 references
eczema
0 references
country
Denmark
0 references
France
0 references
Germany
0 references
India
0 references
Italy
0 references
Japan
0 references
Mexico
0 references
Taiwan
0 references
start time
23 November 2017
0 references
end time
4 January 2019
0 references
number of participants
600
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q64172858&oldid=1857592036"